JP2003520606A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003520606A5 JP2003520606A5 JP2001554422A JP2001554422A JP2003520606A5 JP 2003520606 A5 JP2003520606 A5 JP 2003520606A5 JP 2001554422 A JP2001554422 A JP 2001554422A JP 2001554422 A JP2001554422 A JP 2001554422A JP 2003520606 A5 JP2003520606 A5 JP 2003520606A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- hla
- seq
- restricted
- eso
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17900400P | 2000-01-28 | 2000-01-28 | |
| US60/179,004 | 2000-01-28 | ||
| US23710700P | 2000-09-29 | 2000-09-29 | |
| US60/237,107 | 2000-09-29 | ||
| PCT/US2001/002765 WO2001055393A2 (en) | 2000-01-28 | 2001-01-26 | Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011002419A Division JP5588363B2 (ja) | 2000-01-28 | 2011-01-07 | 癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003520606A JP2003520606A (ja) | 2003-07-08 |
| JP2003520606A5 true JP2003520606A5 (cg-RX-API-DMAC7.html) | 2008-03-13 |
| JP4776852B2 JP4776852B2 (ja) | 2011-09-21 |
Family
ID=26874905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001554422A Expired - Fee Related JP4776852B2 (ja) | 2000-01-28 | 2001-01-26 | 癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ |
| JP2011002419A Expired - Lifetime JP5588363B2 (ja) | 2000-01-28 | 2011-01-07 | 癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011002419A Expired - Lifetime JP5588363B2 (ja) | 2000-01-28 | 2011-01-07 | 癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US7619057B2 (cg-RX-API-DMAC7.html) |
| EP (4) | EP2333065B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4776852B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU785151B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2398743C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001055393A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001055393A2 (en) | 2000-01-28 | 2001-08-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| FR2830940B1 (fr) * | 2001-10-17 | 2007-06-15 | Commissariat Energie Atomique | Procede de selection de ligands d'hla-dp4 et ses applications |
| MXPA04005382A (es) * | 2001-11-07 | 2005-02-24 | Mannkind Corp | Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno. |
| EP1536021A1 (en) * | 2003-11-27 | 2005-06-01 | Consortium National de Recherche en Genomique (CNRG) | Method for HLA typing |
| US7632506B2 (en) * | 2004-09-09 | 2009-12-15 | Ludwig Institute For Cancer Research | Identification of new NY-ESO-1 epitopes recognized by CD4+ T-cells |
| WO2006133497A1 (en) * | 2005-06-15 | 2006-12-21 | Adelaide Research & Innovation Pty Ltd | Combination treatment |
| WO2008017517A1 (en) | 2006-08-11 | 2008-02-14 | Life Sciences Research Partners Vzw | Immunogenic peptides and their use in immune disorders |
| JP4305547B2 (ja) * | 2006-10-27 | 2009-07-29 | エプソンイメージングデバイス株式会社 | 実装構造体、電気光学装置、電子機器及び実装構造体の製造方法 |
| US7893533B2 (en) * | 2006-10-25 | 2011-02-22 | Epson Imaging Devices Corporation | Semiconductor device, mounting structure, electro-optical apparatus, electronic system, and method for manufacturing electronic component |
| WO2009101205A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
| CN107252489A (zh) | 2009-04-13 | 2017-10-17 | 法国健康和医学研究院 | Hpv颗粒及其用途 |
| US9314516B2 (en) * | 2010-05-04 | 2016-04-19 | Cassian Yee | Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| US10023847B2 (en) | 2010-11-25 | 2018-07-17 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
| GB201201511D0 (en) * | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| DK2971045T3 (da) * | 2013-03-13 | 2019-09-16 | Health Research Inc | Sammensætninger og fremgangsmåder til anvendelse af rekombinante T-celle-receptorer til direkte genkendelse af tumorantigen |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| CN105555756B (zh) * | 2013-06-28 | 2018-12-07 | 奥克兰联合服务有限公司 | 氨基酸缀合物和肽缀合物及缀合方法 |
| US10898555B2 (en) * | 2013-07-02 | 2021-01-26 | Japanese Foundation For Cancer Research | Cellular immunity inducing vaccine |
| GB201315946D0 (en) * | 2013-09-06 | 2013-10-23 | Immune Targeting Systems Its Ltd | Oncology vaccine |
| WO2015042325A1 (en) | 2013-09-18 | 2015-03-26 | Aura Biosciences, Inc. | Virus-like particle conjugates for diagnosis and treatment of tumors |
| WO2016014725A1 (en) | 2014-07-22 | 2016-01-28 | The University Of Notre Dame Du Lac | Molecular constructs and uses thereof |
| GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| USD761957S1 (en) | 2014-11-11 | 2016-07-19 | Nuvasive, Inc. | Combined intradiscal insertion tool and intradiscal shim |
| CA2971677A1 (en) | 2014-12-23 | 2016-06-30 | Margaret Anne Brimble | Amino acid and peptide conjugates and uses thereof |
| WO2016128060A1 (en) * | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| EP3067366A1 (en) * | 2015-03-13 | 2016-09-14 | Max-Delbrück-Centrum Für Molekulare Medizin | Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1 |
| US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| EP4339287A3 (en) | 2015-07-31 | 2024-05-22 | Regents Of The University Of Minnesota | Modified cells and methods of therapy |
| CN108601820A (zh) * | 2015-10-12 | 2018-09-28 | 南托米克斯有限责任公司 | 用于病毒癌症新表位的组合物和方法 |
| KR20180095511A (ko) * | 2015-10-30 | 2018-08-27 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 표적화된 암 요법 |
| TW201735952A (zh) | 2016-02-26 | 2017-10-16 | 瑪格蕾特 安 布萊博 | 胺基酸及肽共軛物以及共軛過程 |
| AU2017305396A1 (en) * | 2016-08-02 | 2019-02-21 | Nant Holdings Ip, Llc | Transfection of dendritic cells and methods therefor |
| EP4338799A3 (en) | 2016-10-18 | 2024-06-05 | Regents of the University of Minnesota | Tumor infiltrating lymphocytes and methods of therapy |
| AU2018251788B2 (en) | 2017-04-12 | 2025-04-10 | Aura Biosciences, Inc. | Targeted combination therapy |
| KR102945203B1 (ko) | 2017-05-08 | 2026-03-31 | 시애틀 프로젝트 코포레이션 | 알파바이러스 신생항원 벡터 |
| WO2018224166A1 (en) | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| CN111511375A (zh) | 2017-06-30 | 2020-08-07 | 因提玛生物科学公司 | 用于基因治疗的腺相关病毒载体 |
| TW202000907A (zh) * | 2018-05-23 | 2020-01-01 | 美商葛利史東腫瘤科技公司 | 共有抗原 |
| KR20210090650A (ko) | 2018-11-07 | 2021-07-20 | 그릿스톤 바이오, 인코포레이티드 | 알파바이러스 신생항원 벡터 및 인터페론 억제제 |
| JP7740988B2 (ja) * | 2019-03-12 | 2025-09-17 | バイオエヌテック エスエー | 前立腺癌のための治療用rna |
| US20200318200A1 (en) | 2019-04-02 | 2020-10-08 | The Brigham And Women's Hospital, Inc. | Methods for Identifying Progression of a Primary Melanoma |
| SG11202113187WA (en) | 2019-05-30 | 2021-12-30 | Gritstone Bio Inc | Modified adenoviruses |
| IL300026A (en) | 2020-08-06 | 2023-03-01 | Gritstone Bio Inc | Multiepitope vaccine cassettes |
| CN116732078A (zh) * | 2023-07-21 | 2023-09-12 | 中国人民解放军海军军医大学 | 以pET28a作为载体制备肿瘤相关抗原NY-ESO-1的方法及应用 |
| US20250232833A1 (en) * | 2024-01-13 | 2025-07-17 | Noergaard Anders Kaare | Cyclin D1 Based Cancer Vaccine |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| US4738846A (en) | 1984-08-30 | 1988-04-19 | The Salk Institute For Biological Studies | Vaccine for vesicular stomatitis virus |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5175385A (en) | 1987-09-03 | 1992-12-29 | Ohio University/Edison Animal Biotechnolgy Center | Virus-resistant transgenic mice |
| US6723832B1 (en) * | 1996-10-03 | 2004-04-20 | Ludwig Institute For Cancer Research | Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| AU4058489A (en) | 1988-08-08 | 1990-03-05 | Michael A. Iffiu | Collapsible recumbent bicycle with streamlined three-part folding canopy |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5175383A (en) | 1989-02-17 | 1992-12-29 | President And Fellows Of Harvard College | Animal model for benign prostatic disease |
| CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
| US5174986A (en) | 1989-07-05 | 1992-12-29 | Genpharm International, Inc. | Method for determining oncogenic potential of a chemical compound |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| US6287756B1 (en) * | 1997-05-05 | 2001-09-11 | Ludwig Institute For Cancer Research | Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| DE69837273T2 (de) * | 1997-10-08 | 2008-01-31 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen |
| JP2002506633A (ja) | 1998-03-20 | 2002-03-05 | ジェンザイム・コーポレーション | T細胞応答を誘発するための遺伝子に基づくワクチンの組成物および使用法 |
| US6800730B1 (en) * | 1998-10-02 | 2004-10-05 | Ludwig Institute For Cancer Research | Isolated peptides which bind to MHC class II molecules, and uses thereof |
| JP4615805B2 (ja) | 1999-11-15 | 2011-01-19 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | Ny−eso−1ペプチド誘導体およびその使用 |
| WO2001055393A2 (en) | 2000-01-28 | 2001-08-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
-
2001
- 2001-01-26 WO PCT/US2001/002765 patent/WO2001055393A2/en not_active Ceased
- 2001-01-26 EP EP10010354.8A patent/EP2333065B1/en not_active Expired - Lifetime
- 2001-01-26 US US10/182,506 patent/US7619057B2/en not_active Expired - Fee Related
- 2001-01-26 AU AU33062/01A patent/AU785151B2/en not_active Expired
- 2001-01-26 EP EP10010353A patent/EP2311950A1/en not_active Withdrawn
- 2001-01-26 EP EP01905152A patent/EP1252309A2/en not_active Withdrawn
- 2001-01-26 JP JP2001554422A patent/JP4776852B2/ja not_active Expired - Fee Related
- 2001-01-26 EP EP10010389A patent/EP2311951A1/en not_active Withdrawn
- 2001-01-26 CA CA2398743A patent/CA2398743C/en not_active Expired - Lifetime
-
2009
- 2009-09-28 US US12/568,134 patent/US8754046B2/en not_active Expired - Fee Related
-
2011
- 2011-01-07 JP JP2011002419A patent/JP5588363B2/ja not_active Expired - Lifetime
-
2014
- 2014-05-22 US US14/284,971 patent/US9447144B2/en not_active Expired - Fee Related
-
2016
- 2016-08-19 US US15/241,996 patent/US10251912B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11707512B2 (en) | Cancer vaccine composition | |
| JP5484734B2 (ja) | Hla−a*1101拘束性wt1ペプチド、およびそれを含む医薬組成物 | |
| JP4235984B2 (ja) | Wt1特異的免疫療法のための組成物および方法 | |
| JP5393144B2 (ja) | Hla−a*3303拘束性wt1ペプチド、およびそれを含む医薬組成物 | |
| US10617748B2 (en) | Immunogenic control of tumours and tumour cells | |
| Blake et al. | Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes. | |
| CA2480696C (fr) | Epitopes peptidiques communs a des antigenes d'une meme famille multigenique | |
| US20100015169A1 (en) | Tumor Antigens | |
| JP2003520606A (ja) | 癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ | |
| AU701531B2 (en) | Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor | |
| Vichier‐Guerre et al. | Induction of carbohydrate‐specific antibodies in HLA‐DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use | |
| JPH10511985A (ja) | ヒトグルタミン酸デカルボキシラーゼ(gad)からの自己反応性ペプチド | |
| EP0994948B1 (fr) | Sequence nucleique du recepteur rii du tgfss, peptide code, et utilisations | |
| AU2013270496B2 (en) | Immunogenic control of tumours and tumour cells | |
| WO2003082317A9 (en) | Peptide epitopes recognized by antigen specific cd8+ t lymphocytes | |
| Marquardt et al. | Use of Combinatorial Peptide Libraries to Construct Functional Mimics of Tumor Epitopes Recognized by MHC Class I-Restricted Cytolytic T Lymphocytes By James Blake, Janet V. Johnston, Karl Erik Hellstrtm | |
| AU2016202443A1 (en) | Immunogenic control of tumours and tumour cells | |
| HK1188131A (en) | Immunogenic control of tumours and tumour cells |